Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita
- PMID: 20946585
- DOI: 10.1111/j.1468-3083.2010.03869.x
Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita
Abstract
Background: Several patients, especially women, seek advice because of hair loss. They may be diagnosed clinically as having telogen effluvium (TE) or androgenetic alopecia (AGA), but histopathology may reveal that a proportion of them have in fact alopecia areata incognita (AAI).
Objectives: To detect dystrophic anagen hairs in such patients.
Methods: We studied 1932 patients with hair loss and no signs of classical alopecia areata. They were submitted to the modified wash test (which counts the total number of telogen hairs lost and the percentage of vellus hairs) and divided into patients having pure TE (403), patients with AGA+TE (1235) and patients with pure AGA (294). Dystrophic hairs were detected with a low magnification microscope.
Results: Dystrophic hairs were observed in 13 patients with TE (3.2%), in 54 with AGA+TE (4.4%) and in none with AGA. In addition, 7 patients with TE and 32 with AGA+TE developed small patches of alopecia areata in 6 to 9 weeks. No patches developed in patients with AGA.
Conclusions: The presence of dystrophic hairs and the development of patches of alopecia areata (and their absence in pure AGA) provide a first evidence of the possibility that within the heterogenous condition named TE some patients have in fact AAI.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.
Similar articles
-
Histopathologic features of alopecia areata: a new look.Arch Dermatol. 2003 Dec;139(12):1555-9. doi: 10.1001/archderm.139.12.1555. Arch Dermatol. 2003. PMID: 14676070
-
Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method.Arch Dermatol. 2005 Oct;141(10):1243-5. doi: 10.1001/archderm.141.10.1243. Arch Dermatol. 2005. PMID: 16230561
-
Assessing the reliability of the Modified Wash Test.G Ital Dermatol Venereol. 2011 Aug;146(4):289-94. G Ital Dermatol Venereol. 2011. PMID: 21785395
-
Alopecia in women.Am Fam Physician. 2003 Mar 1;67(5):1007-14. Am Fam Physician. 2003. PMID: 12643360 Review.
-
Diagnosing and treating hair loss.Am Fam Physician. 2009 Aug 15;80(4):356-62. Am Fam Physician. 2009. PMID: 19678603 Review.
Cited by
-
Alopecia Areata Incognita: Current Evidence.Dermatol Ther (Heidelb). 2025 Mar;15(3):635-645. doi: 10.1007/s13555-025-01359-5. Epub 2025 Feb 19. Dermatol Ther (Heidelb). 2025. PMID: 39969772 Free PMC article. Review.
-
Overview of Alopecia: A Dermatopathologist's Perspective.Mo Med. 2015 Jul-Aug;112(4):308-12. Mo Med. 2015. PMID: 26455063 Free PMC article.
-
Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II.An Bras Dermatol. 2012 Nov-Dec;87(6):884-90. doi: 10.1590/s0365-05962012000600010. An Bras Dermatol. 2012. PMID: 23197208 Free PMC article.
-
Telogen effluvium: a comprehensive review.Clin Cosmet Investig Dermatol. 2019 Aug 21;12:583-590. doi: 10.2147/CCID.S200471. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 31686886 Free PMC article. Review.
-
Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale.Int J Womens Dermatol. 2022 Dec 23;8(4):e067. doi: 10.1097/JW9.0000000000000067. eCollection 2022 Dec. Int J Womens Dermatol. 2022. PMID: 36601598 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous